DK1610785T3 - Farmaceutisk kombination til behandlingen af spasticitet og/eller smerte - Google Patents
Farmaceutisk kombination til behandlingen af spasticitet og/eller smerteInfo
- Publication number
- DK1610785T3 DK1610785T3 DK04726223T DK04726223T DK1610785T3 DK 1610785 T3 DK1610785 T3 DK 1610785T3 DK 04726223 T DK04726223 T DK 04726223T DK 04726223 T DK04726223 T DK 04726223T DK 1610785 T3 DK1610785 T3 DK 1610785T3
- Authority
- DK
- Denmark
- Prior art keywords
- spasticity
- treatment
- pain
- pharmaceutical combination
- combination
- Prior art date
Links
- 208000008238 Muscle Spasticity Diseases 0.000 title abstract 2
- 208000018198 spasticity Diseases 0.000 title abstract 2
- MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960001985 dextromethorphan Drugs 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0300929A HUP0300929A3 (en) | 2003-04-09 | 2003-04-09 | Analgetic and/or muscle relaxant pharmaceutical composition |
| PCT/HU2004/000032 WO2004089352A2 (en) | 2003-04-09 | 2004-04-07 | Pharmaceutical combination for the treatment of spasticity and/or pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1610785T3 true DK1610785T3 (da) | 2007-10-22 |
Family
ID=90001682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04726223T DK1610785T3 (da) | 2003-04-09 | 2004-04-07 | Farmaceutisk kombination til behandlingen af spasticitet og/eller smerte |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20060199841A1 (de) |
| EP (1) | EP1610785B1 (de) |
| JP (1) | JP2006522786A (de) |
| AT (1) | ATE370733T1 (de) |
| CY (1) | CY1106903T1 (de) |
| DE (1) | DE602004008440T2 (de) |
| DK (1) | DK1610785T3 (de) |
| EA (1) | EA007732B1 (de) |
| ES (1) | ES2293245T3 (de) |
| HR (1) | HRP20070441T3 (de) |
| HU (1) | HUP0300929A3 (de) |
| NO (1) | NO20055254L (de) |
| PL (1) | PL1610785T3 (de) |
| PT (1) | PT1610785E (de) |
| RS (1) | RS20050738A (de) |
| WO (1) | WO2004089352A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2357808T3 (es) * | 2001-06-07 | 2011-04-29 | Christine Dr. Sang | Tratamiento del dolor neuropático con antagonistas del receptor de n-metil-d-aspartato (nmda). |
| US8262942B2 (en) | 2008-02-07 | 2012-09-11 | The George Washington University | Hollow carbon nanosphere based secondary cell electrodes |
| TR201720289A2 (tr) * | 2017-12-13 | 2019-06-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Tolperizon Ve Selektif COX-2 İnhibitörü Kombinasyonları |
| JP7169580B2 (ja) * | 2018-09-27 | 2022-11-11 | 株式会社Lttバイオファーマ | 線維症治療用医薬組成物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5340779A (en) * | 1976-09-21 | 1978-04-13 | Nippon Kayaku Co Ltd | Optically active tolpertisone, their preparation and pharmaceuticals containting the same |
| US4906638A (en) * | 1987-12-22 | 1990-03-06 | Nova Pharmaceutical Corporation | Dextromethorphan potentiator for anticonvulsant composition and method |
| AU2929489A (en) * | 1987-12-22 | 1989-07-19 | John W. FERKANY | Dextrorphan potentiator for anticonvulsant composition and method |
| US5206248A (en) * | 1992-03-27 | 1993-04-27 | Smith Richard A | Method for reducing emotional lability |
| JP4097285B2 (ja) * | 1994-09-22 | 2008-06-11 | リチャード・アラン・スミス | 種々の頑固な疾患の治療のための医薬の製造に有用な組成物 |
| US5840731A (en) * | 1995-08-02 | 1998-11-24 | Virginia Commonwealth University | Pain-alleviating drug composition and method for alleviating pain |
| AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
| CA2264182A1 (en) * | 1996-08-23 | 1998-02-26 | Algos Pharmaceutical Corporation | Anticonvulsant containing composition for treating neuropathic pain |
| AT409083B (de) * | 1999-04-01 | 2002-05-27 | Sanochemia Pharmazeutika Ag | Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung |
| DE10123129A1 (de) * | 2001-05-02 | 2002-11-14 | Berolina Drug Dev Ab Svedala | Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel |
-
2003
- 2003-04-09 HU HU0300929A patent/HUP0300929A3/hu unknown
-
2004
- 2004-04-07 ES ES04726223T patent/ES2293245T3/es not_active Expired - Lifetime
- 2004-04-07 RS YUP-2005/0738A patent/RS20050738A/sr unknown
- 2004-04-07 PT PT04726223T patent/PT1610785E/pt unknown
- 2004-04-07 AT AT04726223T patent/ATE370733T1/de not_active IP Right Cessation
- 2004-04-07 EP EP04726223A patent/EP1610785B1/de not_active Expired - Lifetime
- 2004-04-07 DE DE602004008440T patent/DE602004008440T2/de not_active Expired - Fee Related
- 2004-04-07 US US10/551,510 patent/US20060199841A1/en not_active Abandoned
- 2004-04-07 PL PL04726223T patent/PL1610785T3/pl unknown
- 2004-04-07 JP JP2006506245A patent/JP2006522786A/ja not_active Withdrawn
- 2004-04-07 WO PCT/HU2004/000032 patent/WO2004089352A2/en not_active Ceased
- 2004-04-07 DK DK04726223T patent/DK1610785T3/da active
- 2004-04-07 EA EA200501591A patent/EA007732B1/ru not_active IP Right Cessation
- 2004-04-07 HR HR20070441T patent/HRP20070441T3/xx unknown
-
2005
- 2005-11-08 NO NO20055254A patent/NO20055254L/no not_active Application Discontinuation
-
2007
- 2007-10-02 CY CY20071101259T patent/CY1106903T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE602004008440T2 (de) | 2008-05-21 |
| EP1610785A2 (de) | 2006-01-04 |
| WO2004089352A3 (en) | 2004-12-16 |
| HUP0300929A3 (en) | 2005-06-28 |
| HUP0300929A2 (hu) | 2005-02-28 |
| PL1610785T3 (pl) | 2008-01-31 |
| US20060199841A1 (en) | 2006-09-07 |
| EP1610785B1 (de) | 2007-08-22 |
| CY1106903T1 (el) | 2012-09-26 |
| HUP0300929D0 (en) | 2003-06-28 |
| NO20055254L (no) | 2006-01-06 |
| JP2006522786A (ja) | 2006-10-05 |
| NO20055254D0 (no) | 2005-11-08 |
| WO2004089352A2 (en) | 2004-10-21 |
| EA007732B1 (ru) | 2006-12-29 |
| ATE370733T1 (de) | 2007-09-15 |
| PT1610785E (pt) | 2007-09-10 |
| HRP20070441T3 (hr) | 2007-10-31 |
| RS20050738A (sr) | 2008-04-04 |
| ES2293245T3 (es) | 2008-03-16 |
| DE602004008440D1 (de) | 2007-10-04 |
| EA200501591A1 (ru) | 2006-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| EA200500203A1 (ru) | Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат | |
| SE0301010D0 (sv) | Novel compounds | |
| SE0301009D0 (sv) | Novel compounds | |
| TW200615266A (en) | Organic compounds | |
| DE60212949D1 (de) | Antivirale pyrazolopyridin verbindungen | |
| SV2004001555A (es) | Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos | |
| SE0302139D0 (sv) | Novel compounds | |
| DK1456212T3 (da) | 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse | |
| TW200616979A (en) | Non-nucleoside reverse transcriptase inhibitors | |
| SE0303541D0 (sv) | New compounds | |
| DK1594885T3 (da) | Lægemiddel til vækstinhibering af tumorer | |
| EA200600605A1 (ru) | Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств | |
| DK1730147T3 (da) | Substituerede 1,4,8-triazaspiro[4.5]decan-2-on-forbindelser til behandling af fedme | |
| SE9804212D0 (sv) | Compounds | |
| DK1511472T3 (da) | Anvendelige forbindelser til behandling af Anthrax og hæmning af letalfaktor | |
| SE0303480D0 (sv) | Benzofuranes | |
| SE0402635D0 (sv) | Chemical compounds | |
| ATE433450T1 (de) | Substituierte 1,4,8-triazaspiro 4.5 decan-2-on- verbindungen | |
| CY1106903T1 (el) | Φαρμακευτικος συνδυασμος για τη θεραπεια της σπαστικοτητας και/ή του πονου | |
| DK1970372T3 (da) | Salte af 9-oxoacridin-10-eddikesyre med 1-alkylamino-1-deoxy-polyoler | |
| SE9904128D0 (sv) | Novel compounds | |
| GB0012795D0 (en) | Organic compounds | |
| DE602004009306D1 (de) | 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern | |
| SE0403117D0 (sv) | New compounds 1 |